Abstract
A characteristic feature of gastrointestinal tract inflammatory disorders, such as inflammatory bowel disease, is polymorphonuclear neutrophil (PMN) transepithelial migration (TEM) and accumulation in the gut lumen. PMN accumulation within the intestinal mucosa contributes to tissue injury. Although epithelial infiltration by large numbers of PMNs results in mucosal injury, we found that PMN interactions with luminal epithelial membrane receptors may also play a role in wound healing. Intercellular adhesion molecule-1 (ICAM-1) is a PMN ligand that is upregulated on apical surfaces of intestinal epithelial cells under inflammatory conditions. In our study, increased expression of ICAM-1 resulted in enhanced PMN binding to the apical epithelium, which was associated with reduced PMN apoptosis. Following TEM, PMN adhesion to ICAM-1 resulted in activation of Akt and β-catenin signaling, increased epithelial-cell proliferation, and wound healing. Such responses were ICAM-1 dependent as engagement of epithelial ICAM-1 by antibody-mediated cross-linking yielded similar results. Furthermore, using an in-vivo biopsy-based, colonic-mucosal-injury model, we demonstrated epithelial ICAM-1 has an important role in activation of epithelial Akt and β-catenin signaling and wound healing. These findings suggest that post-migrated PMNs within the intestinal lumen can regulate epithelial homeostasis, thereby identifying ICAM-1 as a potential therapeutic target for promoting mucosal wound healing.
Original language | English |
---|---|
Pages (from-to) | 1151-1162 |
Number of pages | 12 |
Journal | Mucosal Immunology |
Volume | 9 |
Issue number | 5 |
DOIs | |
State | Published - Sep 1 2016 |
Bibliographical note
Funding Information:We thank Emory University's Digestive Disease Research and Development Center core facility for culturing intestinal epithelial cell lines (supported by National Institutes of Health [NIH] DK064399). This work was supported in part by grants from the NIH (DK072564, DK061379, DK079392 to CP, and DK055679,DK059888 to A.N.),CDAfromthe Crohn's and Colitis Foundation of America to J.C.B., and NIH K01 DK101675 to R.S.
Funding
We thank Emory University's Digestive Disease Research and Development Center core facility for culturing intestinal epithelial cell lines (supported by National Institutes of Health [NIH] DK064399). This work was supported in part by grants from the NIH (DK072564, DK061379, DK079392 to CP, and DK055679,DK059888 to A.N.),CDAfromthe Crohn's and Colitis Foundation of America to J.C.B., and NIH K01 DK101675 to R.S.
Funders | Funder number |
---|---|
Emory University's | |
NIH K01 DK101675 | K01 DK101675 |
National Institutes of Health (NIH) | DK055679, DK064399, DK072564, DK059888, DK061379, DK079392 |
National Childhood Cancer Registry – National Cancer Institute | R01CA179424 |
Crohn's and Colitis Foundation of America | |
National Fisheries Research and Development Institute (NFRDI) | |
Center for Outcomes Research and Evaluation, Yale School of Medicine |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology